Dexmecamylamine Hydrochloride

N/A

Report date: 2024/11/21 20:00:04
NME

Base Information

Drug NameDexmecamylamine Hydrochloride
Drug Alias Namedexmecamilamina盐酸右美卡拉明(S)-(+)-Mecamylamine hydrochloridedexmecamylaminumdexmecamylamine +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic acetylcholine receptor alpha4/beta2/alpha5 antagonistsNeuronal acetylcholine receptor; alpha3/beta4 antagonists
TargetsNicotinic acetylcholine receptor alpha4/beta2/alpha5Neuronal acetylcholine receptor; alpha3/beta4
Therapy Area/IndicationsDepressive Disorder, MajorDepressionSubstance-Related Disorders +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[28] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTargacept Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAtacama Therapeutics IncAstrazeneca PlcTargacept Inc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorDepressionSubstance-Related Disorders +[7] 

Other Information

ATC CodeN/A
Related LinksKEGG